Advertisement

Topics

Amoxicillin Tablets, USP | Amoxicillin

13:48 EDT 24th July 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
IMAGE amoxicillin-str.jpg
* Administered at the start of a light meal.
Mean values of 24 normal volunteers. Peak concentrations occurred approximately 1 hour after the dose.
Dose*
   AUC0-∞ (mcg•hr/mL)
   Cmax (mcg/mL)†   
   Amoxicillin
Amoxicillin
(±S.D.)
Amoxicillin
(±S.D.)
   400 mg (5 mL of suspension)    
17.1 (3.1)
5.92 (1.62)
   400 mg (1 chewable tablet)    
17.9 (2.4)
5.18 (1.64)
   MIC (mcg/mL)   
Interpretation
≤8
   Susceptible (S)   
≥16
   Resistant (R)   
   MIC (mcg/mL)   
   Interpretation   
≤0.25
   Susceptible (S)   
≥0.5
   Resistant (R)   
   MIC (mcg/mL)   
   Interpretation   
≤0.25
   Susceptible (S)   
0.5 to 4
   Intermediate (I)   
≥8
   Resistant (R)   
   MIC (mcg/mL)   
   Interpretation   
≤2
   Susceptible (S)
4
   Intermediate (I)   
≥8
   Resistant (R)   
   MIC (mcg/mL)   
   Interpretation   
≤8
   Susceptible (S)   
16
   Intermediate (I)   
≥32
   Resistant (R)   
   MIC (mcg/mL)   
   Interpretation   
≤1
   Susceptible (S)   
2
   Intermediate (I)   
≥4
   Resistant (R)   
Microorganism
   MIC Range (mcg/mL)   
   E. coli                        ATCC 25922   
2 to 8
   E. faecalis                 ATCC 29212
0.5 to 2
   H. influenzae            ATCC 49247d   
2 to 8
   S. aureus                   ATCC 29213   
0.25 to 1
Microorganism
   MIC Range (mcg/mL)   
   S. pneumoniae         ATCC 49619e   
0.03 to 0.12
   Zone Diameter (mm)   
   Interpretation   
≥17
   Susceptible(S)   
≤16
   Resistant (R)   
   Zone Diameter (mm)   
   Interpretation   
≥29
   Susceptible (S)   
≤28
   Resistant (R)   
   Zone Diameter (mm)   
   Interpretation   
≥26
   Susceptible (S)   
19 to 25
   Intermediate (I)   
≤18
   Resistant  (R)   
   Zone Diameter (mm)   
   Interpretation   
≥17
   Susceptible  (S)   
14 to 16
   Intermediate (I)   
≤13
   Resistant (R)   
   Zone Diameter (mm)   
   Interpretation   
≥22
   Susceptible (S)   
19 to 21
   Intermediate (I)   
≤18
   Resistant (R)   
Microorganism
Zone Diameter (mm)
                        E. coli                     ATCC 25922 
16 to 22
                        H. influenzae          ATCC 49247h   
13 to 21
                        S. aureus                ATCC 25923 
27 to 35
Microorganism
  Zone Diameter (mm) 
                      S. pneumoniae          ATCC 49619
8 to 12
* Dosing for infections caused by less susceptible organisms should follow the recommendations for severe infections.
†  The children’s dosage is intended for individuals whose weight is less than 40 kg. Children weighing 40 kg or more should be dosed according to the adult recommendations.
‡  Each strength of the suspension of amoxicillin is available as a chewable tablet for use by older children.
Infection
Severity*
Usual Adult Dose
Usual Dose for Children
   >3 Months†‡
   Ear/Nose/Throat
   Mild/Moderate
   500 mg every 12 hours
   or
   250 mg every 8 hours
   25 mg/kg/day in divided
   doses every 12 hours
   or
   20 mg/kg/day in divided
   doses every 8 hours
   Severe
   875 mg every 12 hours 
   or
   500 mg every 8 hours
   45 mg/kg/day in divided
   doses every 12 hours
   or
   40 mg/kg/day in divided
   doses every 8 hours
   Lower Respiratory Tract   
   Mild/Moderate 
   or Severe  
   875 mg every 12 hours 
   or
   500 mg every 8 hours
   45 mg/kg/day in divided
   doses every 12 hours
   or
   40 mg/kg/day in divided
   doses every 8 hours
   Skin/Skin Structure
   Mild/Moderate
   500 mg every 12 hours 
   or
   250 mg every 8 hours
   25 mg/kg/day in divided
   doses every 12 hours
   or
   20 mg/kg/day in divided
   doses every 8 hours
   Severe
   875 mg every 12 hours 
   or
   500 mg every 8 hours
   45 mg/kg/day in divided
   doses every 12 hours
   or
   40 mg/kg/day in divided
   doses every 8 hours
   Genitourinary Tract    
   Mild/Moderate
   500 mg every 12 hours 
   or
   250 mg every 8 hours
   25 mg/kg/day in divided
   doses every 12 hours
   or
   20 mg/kg/day in divided
   doses every 8 hours
   Severe
   875 mg every 12 hours 
   or
   500 mg every 8 hours
   45 mg/kg/day in divided
   doses every 12 hours
   or
   40 mg/kg/day in divided
   doses every 8 hours
   Gonorrhea Acute,
   uncomplicated
   ano-genital and
   urethral infections
   in males and females

 
   3 grams as single oral 
   dose   
   Prepubertal children:
   50 mg/kg amoxicillin,    
   combined with 25 mg/kg   
   probenecid as a single   
   dose.
   NOTE: SINCE
   PROBENECID IS
   CONTRAINDICATED
   IN CHILDREN UNDER   
   2 YEARS, DO NOT USE   
   THIS REGIMEN IN
   THESE CASES.
H. pylori Eradication Rates – Triple Therapy (amoxicillin/clarithromycin/lansoprazole) Percent of Patients Cured [95% Confidence Interval] (Number of Patients)
* This analysis was based on evaluable patients with confirmed duodenal ulcer (active or within 1 year) and H. pylori infection at baseline defined as at least 2 of 3 positive endoscopic tests from CLOtest®, (Delta West Ltd., Bentley, Australia), histology, and/or culture. Patients were included in the analysis if they completed the study. Additionally, if patients dropped out of the study due to an adverse event related to the study drug, they were included in the analysis as failures of therapy.
Patients were included in the analysis if they had documented H. pylori infection at baseline as defined above and had a confirmed duodenal ulcer (active or within 1 year). All dropouts were included as failures of therapy.
(p<0.05) versus lansoprazole/amoxicillin and lansoprazole/clarithromycin dual therapy.
§ (p<0.05) versus clarithromycin/amoxicillin dual therapy.
Study
Triple Therapy
Triple Therapy
Evaluable Analysis*
Intent-to-Treat Analysis
Study 1
92
[80 - 97.7]
(n = 48)
86
[73.3 - 93.5]
(n = 55)
Study 2
86§
[75.7 - 93.6]
(n = 66)
83§
[72 - 90.8]
(n = 70)
H. pylori Eradication Rates – Dual Therapy (amoxicillin/lansoprazole) Percent of Patients Cured [95% Confidence Interval] (Number of Patients)
* This analysis was based on evaluable patients with confirmed duodenal ulcer (active or within 1 year) and H. pylori infection at baseline defined as at least 2 of 3 positive endoscopic tests from CLOtest®, histology, and/or culture. Patients were included in the analysis if they completed the study. Additionally, if patients dropped out of the study due to an adverse event related to the study drug, they were included in the analysis as failures of therapy.
Patients were included in the analysis if they had documented H. pylori infection at baseline as defined above and had a confirmed duodenal ulcer (active or within 1 year). All dropouts were included as failures of therapy.
(p<0.05) versus lansoprazole alone.
§ (p<0.05) versus lansoprazole alone or amoxicillin alone.
Study
Dual Therapy
Dual Therapy
Evaluable Analysis*
Intent-to-Treat Analysis
Study 1
77
[62.5 - 87.2]
(n = 51)
70
[56.8 - 81.2]
(n = 60)
Study 2
66§
[51.9 - 77.5]
(n = 58)
61§
[48.5 - 72.9]
(n = 67)
IMAGE amoxicillin-fig1.jpgIMAGE amoxicillin-fig2.jpg

Manufacturer

Aurobindo Pharma Limited

Active Ingredients

Source

Clinical Trials [208 Associated Clinical Trials listed on BioPortfolio]

Short Course of Amoxicillin for Erysipelas

The propose of this study is to determine whether a 6-day duration of oral amoxicillin treatment of erysipelas is non-inferior to a 14-day standard duration intravenous then oral amoxicill...

Amoxicillin Susceptibility of Oral Streptococci After a 3-Day or a 7-Day Amoxicillin Therapy

Antibiotic resistance is a worldwide problem closely linked to antibiotic consumption. To limit the risk to select resistant bacteria, the rules of prescription are to use high doses and s...

Treatment of Acute Sinusitis With High-Dose vs. Standard-Dose Amoxicillin/Clavulanate

Comparative-effectiveness study of the treatment of acute bacterial sinusitis with amoxicillin/clavulanate 875mg/125mg bid for 7 days with or without the addition of immediate-release amox...

Effect of Stomach Reduction Surgery on the Parameters of Amoxicillin

The objective of this study was to evaluate the impact of bariatric surgery on the pharmacokinetics of amoxicillin. Methods: This study was performed as a randomized, open-label, single-d...

Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal- Tonsillitis in Pediatric Patients

The purpose of this study is to evaluate the inflammatory symptoms and signs (hyperemia, edema and pain) reduction after 24 hours of treatment with ketoprofen drops when associated to amox...

PubMed Articles [83 Associated PubMed Articles listed on BioPortfolio]

Evaluation of the amoxicillin concentrations in amniotic fluid, placenta, umbilical cord blood and maternal serum two hours after oral administration.

Amoxicillin is a broad-spectrum beta-lactam antibiotic. Due to its low toxicity, it is commonly used in obstetrics. The objective of this study was to assess amoxicillin concentrations in amniotic flu...

Phytotoxicity of amoxicillin to the duckweed Spirodela polyrhiza: Growth, oxidative stress, biochemical traits and antibiotic degradation.

The increasing availability of antibiotics in wastewater has created a serious threat to non-target organisms in the environment. The aim of this study was to evaluate the potential toxicity of amoxic...

Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.

An optimum Helicobacter pylori-eradication regimen for hemodialysis patients is yet to be established because of different pharmacokinetics of amoxicillin involved between hemodialysis patients and he...

Effectiveness of amoxicillin alone in the treatment of uncomplicated acute otitis media: a systematic review protocol.

Amoxicillin is the first-line antibiotic recommended by most scientific societies for the treatment of uncomplicated acute otitis media (AOM) in children and adults. In low-income and middle-income co...

Novel amoxicillin nanoparticles formulated as sustained release delivery system for poultry use.

Amoxicillin is used in the treatment and prevention of a wide range of diseases in poultry breeding. However, its short half-life and low bioavailability restrict its clinical application in these spe...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record